Reach-through claims for drug target patents: Rx for pharmaceutical policy :
When a major chunk of scientific community debate for a free world (GNU), here comes a new development; patent the targets and earn money through the drugs acting on it.. Who'll finally pay for it? The unfortunate patients..
However this will be a motivating news to the biologist/pharmacologist who work hard to find novel targets but who are usually least benefited in monetary terms. It is crucial to make a fool-proof patent law in this regard. Otherwise, it'll hinder not only the scientific freedom but also treatment availability to the poor suffering patients.